Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]A Review of its Use as an Active Immunization Against Influenza A Subtype H5N1 Virus

被引：0
|
作者：
Natalie J. Carter
Greg L. Plosker
机构：
[1] Wolters Kluwer Health ¦ Adis,
[2] Wolters Kluwer Health,undefined
来源：
BioDrugs | 2008年 / 22卷
关键词：
Influenza; Influenza Vaccine; Vaccine Strain; Seasonal Influenza; Influenza Pandemic;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：279 / 292
页数：13
相关论文
共 50 条
  • [21] Avian Influenza A H5N1 Virus
    Loeffelholz, Michael J.
    CLINICS IN LABORATORY MEDICINE, 2010, 30 (01) : 1 - +
  • [22] Development of DNA Vaccine against Avian Influenza A Virus (H5N1)
    Ahmed, Shaheen
    Bronich, Tatiana K.
    Kabanov, Alexander V.
    MOLECULAR THERAPY, 2011, 19 (07) : 1392 - 1393
  • [23] Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes
    Wu, J.
    Zhang, F.
    Fang, F.
    Chang, H.
    Wang, F.
    Yang, Z.
    Sun, B.
    Chen, Z.
    VACCINE, 2010, 28 (15) : 2775 - 2781
  • [24] A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge
    Smith, Douglas
    Streatfield, Stephen J.
    Acosta, Hugo
    Ganesan, Shyamala
    Fattom, Ali
    VACCINE, 2019, 37 (42) : 6162 - 6170
  • [25] Determinants of Antiviral Effectiveness in Influenza Virus A Subtype H5N1
    Chan, Paul K. S.
    Lee, Nelson
    Zaman, Mukhtiar
    Adisasmito, Wiku
    Coker, Richard
    Hanshaoworakul, Wanna
    Gasimov, Viktor
    Oner, Ahmet Faik
    Dogan, Nazim
    Tsang, Owen
    Phommasack, Bounlay
    Touch, Sok
    Bamgboye, Ebun
    Swenson, Anna
    Toovey, Stephen
    Dreyer, Nancy A.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (09): : 1359 - 1366
  • [26] Highly pathogenic avian influenza A virus (subtype H5N1)
    Kozak, Robert
    Bogoch, Isaac I.
    Mubareka, Samira
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (32) : E1129 - E1130
  • [27] Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice
    Harada, Yuichi
    Ninomiya-Mori, Ai
    Takahashi, Yoshimasa
    Shirakura, Masayuki
    Kishida, Noriko
    Kageyama, Tsutomu
    Tada, Yoshikazu
    Tashiro, Masato
    Odagiri, Takato
    VACCINE, 2011, 29 (46) : 8330 - 8337
  • [28] Generation and characterisation of monoclonal antibodies against influenza virus A, subtype H5N1
    Linke, Sonja
    Neubauer, Katrin
    Dorner, Martin B.
    Dorner, Brigitte G.
    Pauli, Georg
    Schweiger, Brunhilde
    JOURNAL OF VIROLOGICAL METHODS, 2011, 175 (01) : 85 - 94
  • [29] Pandemic and prepandemic H5N1 influenza vaccines: a 2009 update
    Loulergue, Pierre
    Launay, Odile
    M S-MEDECINE SCIENCES, 2009, 25 (8-9): : 719 - 725
  • [30] Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
    Hoschler, Katja
    Gopal, Robin
    Andrews, Nick
    Saville, Melanie
    Pepin, Stephanie
    Wood, John
    Zambon, Maria C.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2007, 1 (5-6) : 199 - 206
12345